# NEOPAN (NCT02539537)

> A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02539537
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: UNICANCER
- Conditions: Pancreatic Cancer; Carcinoma
- Interventions: Gemcitabine; Folinic Acid; 5-Fluoro-uracil; Oxaliplatin; Irinotecan; L-folinic
- Enrollment: 171
- Primary outcome: Progression-Free-Survival (PFS)

## Commentary we found

- X threads: 11
- YouTube: 3

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=neopan-nct02539537

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02539537", "email": "<work email>"}; the inbox owner confirms by the emailed link.